Journey Medical (DERM) Return on Invested Capital (2022 - 2026)

Journey Medical's (DERM) quarterly Return on Invested Capital came in at 0.01% in Q4 2025, down 9.58% on a QoQ basis from 0.01% in Q3 2025.

Journey Medical (DERM) Return on Invested Capital (2022 - 2026) Analysis & Trends

Journey Medical (DERM) has 3 years of Return on Invested Capital data on file, last reported at 0.01% in Q4 2025.

Quarterly Return on Invested Capital changed N/A year-over-year to 0.01% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.01% (changed N/A YoY) and the FY2022 annual result came in at 0.15%, changed N/A from the prior year.
Return on Invested Capital fell to 0.01% in Q4 2025, from 0.01% in the prior quarter.
In the past five years, Return on Invested Capital ranged from a high of 0.0% in Q4 2023 to a low of 0.46% in Q1 2022.
A 3-year average of 0.16% and a median of 0.02% in 2025 frame the typical range for Return on Invested Capital.
The widest YoY moves for Return on Invested Capital: up 41 bps in 2023, down 15 bps in 2023.
Tracing DERM's Return on Invested Capital over 3 years: stood at 0.15% in 2022, then surged by 99 bps to 0.0% in 2023, then plunged by 611 bps to 0.01% in 2025.
The last three Return on Invested Capital figures came in at 0.01% (Q4 2025), 0.01% (Q3 2025), and 0.02% (Q2 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	ROIC (Qtr)
1	Haleon	43.98 Bn	43.02 Bn	-	-
2	Teva Pharmaceutical Industries	43.28 Bn	39.62 Bn	2.15 Bn	0.00%
3	Zoetis	31.78 Bn	30.11 Bn	1.05 Bn	-
4	Takeda Pharmaceutical	28.71 Bn	22.91 Bn	5.10 Bn	0.00%
5	United Therapeutics	22.25 Bn	19.59 Bn	683.80 Mn	-
6	Viatris	18.72 Bn	17.83 Bn	1.46 Bn	0.00%
7	Neurocrine Biosciences	15.57 Bn	15.18 Bn	935.80 Mn	-
8	Elanco Animal Health	11.87 Bn	11.34 Bn	798.00 Mn	0.03%
9	Dr Reddys Laboratories	10.14 Bn	9.97 Bn	-	-
10	Journey Medical	209.21 Mn	183.57 Mn	12.37 Mn	0.00%

Download Data